InvestorsHub Logo
Followers 26
Posts 1792
Boards Moderated 0
Alias Born 08/07/2022

Re: BIOChecker4 post# 464136

Sunday, 07/14/2024 1:51:31 PM

Sunday, July 14, 2024 1:51:31 PM

Post# of 464749
Who could argue that the Rett juvenile trial was not a failure. It was. Sure, it showed a very strong signal - much greater effect than the existing approved therapy - still the trial was badly designed and failed to show statistical signficance. My hope is that Anavex gets on their horse and re-runs a better designed juvenile trial. Like yesterday.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News